Michael Steinberg MD

Chairman, UCLA Radiation Oncology
Views are my own

[Michael Steinberg MD @MSteinbergMD]

Proud to share the SS25 UCLA Radiation Oncology Journal.

This issue features Francesco Clemente. Richard Deming and his book, This Exquisite Loneliness. Leanne Ford as our Featured Designer. And Yale Younger, Richard Siken as our Featured Poet.

https://t.co/SlKMW5buZv

[Michael Steinberg MD @MSteinbergMD]

Chief of Thoracic Oncology in the Department of Radiation Oncology, @DrewMoghanaki, on how "treatment decisions can also be shaped by fatalism—the lingering belief that metastatic lung cancer is hopeless."

[Michael Steinberg MD @MSteinbergMD]

@DrewMoghanaki, Chief of Thoracic Oncology in the Department of Radiation Oncology at UCLA, on how "treatment decisions can also be shaped by fatalism—the lingering belief that metastatic lung cancer is hopeless."

Read more:
https://t.co/OjoVWsnYKt

[Michael Steinberg MD @MSteinbergMD]

Congratulations to UCLA Radiation Oncology's @JieDengMDPhD on her Holman project.

Read More Here: https://t.co/R6h62zv9r9

UCLA Rad. Onc. Co-Authors include Dr. Dorthe Schaue and Dr. Vish Reddy

[Michael Steinberg MD @MSteinbergMD]

A new study led by @AmarUKishan

Read more: https://t.co/3iT1IjpOfL

[Michael Steinberg MD @MSteinbergMD]

Proud to share that UCLA Radiation Oncology is now in El Segundo.

https://t.co/axIhEWANf9

[Michael Steinberg MD @MSteinbergMD]

UCLA Radiation Oncology's Dr. @DrewMoghanaki emphasizes the national importance of lung cancer screening to the @nytimes in reference to a recent JAMA publication from scientists at the American Cancer Society.

Read the piece here: https://t.co/pUD3OHib3t

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

#LungCancer screening saves lives — but current criteria miss nearly half of future cases. Dr. Drew Moghanaki explains why change is needed. More from @nytimes: https://t.co/C7kw7xYVp6

[Drew Moghanaki @DrewMoghanaki]

🫁 I’m proud to be at an institution that keeps our patients informed about the most important issues. @dramycummings @AshleyEProsper

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

A new @JAMAOnc study co-led by @AmarUKishan suggests shorter courses of androgen deprivation therapy may reduce risks while maintaining effective cancer control. https://t.co/53h7XKEd5M

[Trudy Wu, MD @TrudyWuMD]

My first #ASTRO as @UCLA faculty. What an enjoyable time with my rad onc family! Leaving the Bay inspired and optimistic for the future of cancer care

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

Congratulations to @AmarUKishan on receiving the 2025 Steven A. Leibel Memorial Award, one of the highest honors in radiation oncology, presented by @ASTRO_org and @ABR_Radiology.

https://t.co/YcE2glkzXN

[Trudy Wu, MD @TrudyWuMD]

@UCLA Rad Onc residents locking in on their research at #ASTRO2025 🤩 so proud!

Highlights from Mon feat. PGY5 Travis Courtney, PGY3s Nic Nelson and Mimi Lane, and former resident (now @StanfordRadOnc faculty) Beth Neilsen.

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

New 4-year results from the SCIMITAR trial, led by @AmarUKishan & @MSteinbergMD and published in @EUplatinum, show that SBRT after prostate surgery is safe, effective & comparable to standard radiation.
https://t.co/gFdUT1j84j

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

Congratulations to @DrewMoghanaki on this well-deserved recognition!

[Amar Kishan @AmarUKishan]

@JesusJ_MD presenting 4-year outcomes of post-op SBRT on the phase II SCIMITAR trial — in press soon!

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

Don't miss @TrudyWuMD at #ASTRO25 moderating a panel on using digital tools to make cancer education more understandable. Experts and a patient advocate share strategies, videos & resources to help empower patients in their cancer journey.

Learn more: https://t.co/ErxiNz4yPB

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

Just in from #ASTRO25: @AmarUKishan & @CalaisJeremie report adding PSMA-targeted radioligand therapy before SBRT more than doubled progression-free survival in men with recurrent prostate cancer (17.6 vs 7.4 months), delaying the need for hormone therapy. https://t.co/dsFByW5M3p

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

Don’t miss Dr. Jonathan Massachi at #ASTRO25 sharing MIRAGE trial results on sexual function in men receiving SBRT for prostate cancer, comparing CT-guided vs MRI-guided treatment.

Learn more: https://t.co/DbaTKMhKk5

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

This morning at #ASTRO25, Dr. Travis Courtney will discuss research that compares the side effects of standard high-dose MRgSBRT with an adaptive dose-painted approach that boosts radiation to tumor areas while sparing surrounding tissue.

Learn more: https://t.co/JhZoudiTfD

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

Today, Dr. Miriam Lane will present new findings at #ASTRO25 on postoperative SBRT for patients with newly diagnosed or recurrent head and neck cancer.

Learn more: https://t.co/BnLaSUpMkl